Please login to the form below
stroke
This page shows the latest stroke news and features for those working in and with pharma, biotech and healthcare.
LifeArc partners with UK Dementia Research Institute
Dementia is one of the main causes of disability later in life, ahead of cancer, cardiovascular disease and stroke.
Latest news
-
NICE recommends Vazkepa for patients at risk of stroke and heart attacks in England and Wales
These events include a composite of CV death, non-fatal myocardial infarction, non-fatal stroke, coronary revascularisation or hospitalisation for angina.
-
UK’s NICE recommends anti-cholesterol Leqvio for high-risk patients
primary hypercholesterolaemia or mixed dyslipidaemia who have already had a cardiovascular event such as a heart attack or stroke. ... Inclisiran represents a potential game-changer in preventing thousands of people from dying prematurely from heart
-
Lexicon Pharma announces strong CV data for first-in-class sotagliflozin at the European Society of Cardiology’s annual meeting
Sotagliflozin robustly and significantly reduced heart failure hospitalisations, myocardial infarction and stroke,” said study chair Deepak Bhatt, from Brigham and Women's Hospital and Harvard Medical School. ... Although direct, head-to-head clinical
-
FDA questions safety profile of AZ, FibroGen’s anaemia drug roxadustat
Looking at this group in particular, patients on roxadustat did better than those on epoetin alfa on so-called MACE+, which includes all-cause mortality, stroke and myocardial infarction (MACE) as
-
BMS builds case for cardiovascular drug mavacamten with new analysis
In both obstructive or non-obstructive HCM patients, physical exertion can cause fatigue or shortness of breath, and has also been associated with increased risks of atrial fibrillation, stroke, heart failure
More from news
Approximately 15 fully matching, plus 506 partially matching documents found.
Latest Intelligence
-
Understand, identify and partner with HCPs to improve patient support
patients are at risk of heart failure or stroke.
-
Pharma funding and M&A in 2020
Indeed, 2019 was notable for Bristol-Myers Squibb’s acquisition of Celgene (which at a stroke bolstered its immunotherapy and oncology departments), as well as AbbVie’s acquisition of Allergan for
-
Case study: What we're made of
This could be a side effect of a condition such as stroke, motor neurone disease, multiple sclerosis, learning disability, dementia, Parkinson’s disease, head and neck injury or cancer.
-
The evolution of marketing – the Amgen way
Yet, cardiovascular disease is still the leading cause of death in Europe, and 80% of premature cases of heart disease and stroke are preventable.
-
AstraZeneca’s oncology renaissance
This saw phase 3 flops of drugs for stroke, prostate cancer and depression – failures that dented confidence in the firm as patent expiries for its blockbusters Crestor and Nexium loomed on
More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.
Latest appointments
-
Hanover Health appoints two new associate directors
MacDonald (pictured right) joins from the Stroke Association, where he worked for just over five years.
-
Dr Hamina Patel moves from J&J to Evgen Pharma
Evgen's lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke and the firm is also carrying out preclinical work in multiple sclerosis and has a clinical
-
Turing names Eliseo Salinas as head of R&D
epilepsy, stroke, Parkinson's, attention deficit disorder and Alzheimer's disease.
-
Acorda appoints new CFO
This growth is led by six therapies in clinical studies that address a range of disorders including post-stroke deficits, epilepsy, cerebral palsy, stroke, peripheral nerve damage, spinal cord injury, neuropathic
More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest from PMHub
-
EQUAL FOOTING: HOW PHARMA CAN HELP THE NHS TO ACT ON HEALTH INEQUALITIES
some of the highest AF-related stroke rates in the country.
-
Cardiovascular disease: The scale of the challenge
As part of efforts set out in NHS England’s Long Term Plan to prevent 150, 000 deaths over the next decade from the likes of heart attacks and strokes, the ... Thousands of cases of stroke, diabetes, heart failure and kidney disease could and should be
-
Black community representation in clinical trials
This Black History Month, we discuss the black representation in clinical trials and the effects COVID-19 has had on the black community. Innovative Trials are passionate about ensuring our diverse population is adequately represented within medical
-
Clinical trial design and how it can be used to improve the patient experience
These trial designs only have one treatment option, with no placebo, and are usually in clinical fields such as cancer or stroke where patients experience acute illness and may not have
-
Choose to challenge for women’s health on this International Women's Day
Yet, an analysis of data from ClinicalTrials.gov found that women represented less than 40% of the people enrolled in heart disease and stroke clinical research.
More from PMHub
Approximately 1 fully matching, plus 30 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis publishes final positive phase 3 results of Zolgensma in Nature Medicine
- Myovant Sciences and Pfizer publish phase 3 results for endometriosis therapy
- Bristol Myers Squibb announces positive trial results for treatment of MS
- FDA grants Pfizer/BioNTech’s COVID-19 vaccine emergency use authorisation for infants
- Virtual MSL/Sales training programs and events
- 6 trends shaping the future of personalized medicine
- Omnichannel strategies to revolutionize the healthcare professional experience
- The digital-first launch: the key to connected stakeholder experiences?
- Pfizer and BioNTech share positive results for Omicron-adapted COVID-19 vaccine
- Bristol Myers Squibb announces positive trial results for treatment of MS
- MSD and AstraZeneca announce phase 3 results for prostate cancer therapy
- Roche shares new positive Ocrevus data for MS patients
- College of Medicine launches Beyond Pills campaign to tackle overprescribing in UK health system
- Annovis Bio’s lead therapeutic shows ‘significant improvements’ in Alzheimer’s, Parkinson’s
- Phase 3 trial initiated to evaluate AZ's Saphnelo in lupus nephritis
- New virtual health and care report from WHO and Novartis calls for ‘critical action’
PMHub
Aptus Health
Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...
Latest intelligence
- Virtual MSL/Sales training programs and events
- Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
- 6 trends shaping the future of personalized medicine
- Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
- Omnichannel strategies to revolutionize the healthcare professional experience
- Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...
